Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Extensive Stage Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05309629
What this trial is testing

Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy in Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Qilu Pharmaceutical Co., Ltd. 40
Testing effectiveness (Phase 2)Looking for participantsNCT06768307
What this trial is testing

Assessment of Adebelizumab Combined With Chemotherapy in Concurrent Radiotherapy Versus Sequential Radiotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer

Who this might be right for
SCLC, Extensive StageImmunotherapyChemotherapy+1 more
Peking University Cancer Hospital & Institute 60
Not applicableStudy completedNCT05055947
What this trial is testing

Efficacy Biomarker Investigation on Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Hunan Province Tumor Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT07508852
What this trial is testing

68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer

Who this might be right for
SCLCSCLC, Extensive StageSCLC, Limited Stage+2 more
Peking University First Hospital 30
Large-scale testing (Phase 3)Study completedNCT04878016
What this trial is testing

Carboplatin Plus Etoposide With or Without ZKAB001 (Anti-PD-L1 Antibody) in Patients With ES-SCLC

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Lee's Pharmaceutical Limited 498
Testing effectiveness (Phase 2)Study completedNCT00009971
What this trial is testing

Fenretinide in Treating Patients With Recurrent Small Cell Lung Cancer

Who this might be right for
Lung Cancer
National Cancer Institute (NCI) 32
Testing effectiveness (Phase 2)Looking for participantsNCT04696575
What this trial is testing

Lamivudine in Combination With Chemoimmunotherapy for the Treatment of Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Lung Small Cell Carcinoma
Roswell Park Cancer Institute 28
Early research (Phase 1)Active Not RecruitingNCT06077500
What this trial is testing

DAREONᵀᴹ-8: A Study to Test How Well Different Doses of BI 764532 in Addition to Standard of Care Are Tolerated by People With Advanced Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma (SCLC)
Boehringer Ingelheim 46
Testing effectiveness (Phase 2)Study completedNCT00003565
What this trial is testing

Docetaxel in Treating Patients With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerHead and Neck Cancer+2 more
Alliance for Clinical Trials in Oncology 109
Testing effectiveness (Phase 2)Looking for participantsNCT07423585
What this trial is testing

Tarlatamab for the Treatment of Extensive Stage Small-cell Lung Cancer

Who this might be right for
Extensive Stage Lung Small Cell Carcinoma
Asrar Alahmadi 39
Not applicableStudy completedNCT00404365
What this trial is testing

Depression Screening in Patients With Lung Cancer

Who this might be right for
DepressionLung Cancer
Memorial Sloan Kettering Cancer Center 241
Testing effectiveness (Phase 2)Ended earlyNCT04610684
What this trial is testing

Chemotherapy and Atezolizumab for Patients With Extensive Stage Small Cell Lung Cancer (SCLC) With Untreated, Asymptomatic Brain Metastases

Who this might be right for
Small-cell Lung CancerBrain Metastases
Jeffrey Clarke 3
Not applicableNot Yet RecruitingNCT07173946
What this trial is testing

Prospective Observational Study on ES-SCLC

Who this might be right for
Extensive-stage Small-cell Lung CancerSmall Cell Lung Cancer
Peking Union Medical College Hospital 96
Testing effectiveness (Phase 2)UnknownNCT04967625
What this trial is testing

A Phase II Study of Sintilimab Combined With Anlotinib in Treatment of ED-SCLC

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Zhejiang Cancer Hospital 23
Testing effectiveness (Phase 2)Study completedNCT01331525
What this trial is testing

The Addition of Ipilimumab to Carboplatin and Etoposide Chemotherapy for Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung Cancer
University Hospital Southampton NHS Foundation Trust 42
Testing effectiveness (Phase 2)Study completedNCT04636762
What this trial is testing

Concurrent Chemoradiation With Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Second Xiangya Hospital of Central South University 40
Large-scale testing (Phase 3)Study completedNCT01450761
What this trial is testing

Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone

Who this might be right for
Small Cell Lung Carcinoma
Bristol-Myers Squibb 1,351
Testing effectiveness (Phase 2)Study completedNCT00528645
What this trial is testing

AZD0530 in Treating Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung CancerLung MetastasesMalignant Pleural Effusion+1 more
National Cancer Institute (NCI) 23
Testing effectiveness (Phase 2)Looking for participantsNCT06739928
What this trial is testing

Irinotecan Liposome (II) or Etoposide Combined With Adebrelimab and Carboplatin in the Treatment of ES-SCLC

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Guangzhou Institute of Respiratory Disease 120
Testing effectiveness (Phase 2)Study completedNCT03043599
What this trial is testing

Ipilimumab + Nivolumab w/Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung CancerExtensive-stage Small Cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 21
Next Page